RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Medical System Holdings Stock

China Medical System Holdings ROA 2024

China Medical System Holdings ROA

0.14

Ticker

867.HK

ISIN

KYG211081248

WKN

A1JLYP

In 2024, China Medical System Holdings's return on assets (ROA) was 0.14, a -26.23% increase from the 0.18 ROA in the previous year.

China Medical System Holdings Aktienanalyse

What does China Medical System Holdings do?

China Medical System Holdings Ltd is a leading pharmaceutical conglomerate specializing in the development, manufacturing, and marketing of drugs in China. The company was founded in 1995 and is headquartered in Shenzhen. The history of China Medical System began as a small company based in Hong Kong, specializing in the import of drugs from Europe and the United States. In 2004, the company expanded its business into the Chinese market and began marketing products in China. Through a consistent expansion strategy and targeted investments, the company was able to become a major player in the Chinese pharmaceutical market in a short period of time. Today, China Medical System is one of the largest pharmaceutical companies in China with a wide portfolio of products and services. China Medical System's business model is focused on marketing drugs in China. The company works closely with its international partners and licenses their products for the Chinese market. In addition, China Medical System has its own research and development departments that work on developing new drugs for the Chinese market. The various divisions of China Medical System encompass a wide range of products and services. The company operates in the areas of preparative chemistry, clinical development, pharmaceutical distribution, and marketing. The company also offers services such as clinical trials and other consulting services. Some of China Medical System's most well-known products include the anti-tumor drug Endostar, used for the treatment of lung cancer, and the hepatitis B drug Fufangdanshen. The company has also entered into a number of collaboration agreements with international pharmaceutical companies such as Sanofi and Eli Lilly to market their products in China. Overall, the company has built a strong position in the Chinese market throughout its history and makes significant contributions to the research, development, and marketing of drugs in China. China Medical System Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding China Medical System Holdings's Return on Assets (ROA)

China Medical System Holdings's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing China Medical System Holdings's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider China Medical System Holdings's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in China Medical System Holdings’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about China Medical System Holdings stock

What is the Return on Assets (ROA) of China Medical System Holdings this year?

The Return on Assets (ROA) of China Medical System Holdings is 0.14 undefined this year.

What was the ROA of China Medical System Holdings compared to the previous year?

The ROA of China Medical System Holdings has increased by -26.23% compared to the previous year.

What consequences do high ROA have for investors of China Medical System Holdings?

A high ROA is advantageous for investors of China Medical System Holdings, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in China Medical System Holdings?

A low ROA can be unfavorable for investors of China Medical System Holdings as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of China Medical System Holdings affect the company?

An increase in ROA of China Medical System Holdings can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of China Medical System Holdings impact the company?

A reduction in the ROA of China Medical System Holdings can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of China Medical System Holdings?

Some factors that can influence the ROA of China Medical System Holdings include revenue, operating costs, asset structure, and industry average.

Why is the ROA of China Medical System Holdings important for investors?

The ROA of China Medical System Holdings is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can China Medical System Holdings take to improve ROA?

To improve ROA, China Medical System Holdings can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does China Medical System Holdings pay?

Over the past 12 months, China Medical System Holdings paid a dividend of 0.62 CNY . This corresponds to a dividend yield of about 8.53 %. For the coming 12 months, China Medical System Holdings is expected to pay a dividend of 0.69 CNY.

What is the dividend yield of China Medical System Holdings?

The current dividend yield of China Medical System Holdings is 8.53 %.

When does China Medical System Holdings pay dividends?

China Medical System Holdings pays a quarterly dividend. This is distributed in the months of June, June, September, September.

How secure is the dividend of China Medical System Holdings?

China Medical System Holdings paid dividends every year for the past 17 years.

What is the dividend of China Medical System Holdings?

For the upcoming 12 months, dividends amounting to 0.69 CNY are expected. This corresponds to a dividend yield of 9.58 %.

In which sector is China Medical System Holdings located?

China Medical System Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Medical System Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Medical System Holdings from 9/9/2024 amounting to 0.02 CNY, you needed to have the stock in your portfolio before the ex-date on 8/30/2024.

When did China Medical System Holdings pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of China Medical System Holdings in the year 2023?

In the year 2023, China Medical System Holdings distributed 0.616 CNY as dividends.

In which currency does China Medical System Holdings pay out the dividend?

The dividends of China Medical System Holdings are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Medical System Holdings

Our stock analysis for China Medical System Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Medical System Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.